VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 224 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $541,190 | -66.0% | 23,257 | -63.0% | 0.00% | -75.0% |
| Q4 2022 | $1,592,632 | +29.4% | 62,925 | -1.5% | 0.01% | +33.3% |
| Q3 2022 | $1,231,000 | +212.4% | 63,874 | +313.2% | 0.01% | +200.0% |
| Q2 2022 | $394,000 | -61.9% | 15,460 | -61.5% | 0.00% | -50.0% |
| Q1 2022 | $1,033,000 | +39.0% | 40,149 | +126.2% | 0.00% | +33.3% |
| Q4 2021 | $743,000 | +52.9% | 17,752 | +58.9% | 0.00% | +50.0% |
| Q3 2021 | $486,000 | -8.0% | 11,171 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $528,000 | -12.4% | 11,161 | -5.1% | 0.00% | -33.3% |
| Q1 2021 | $603,000 | -10.4% | 11,761 | -53.2% | 0.00% | 0.0% |
| Q4 2020 | $673,000 | +49.9% | 25,114 | +92.0% | 0.00% | +50.0% |
| Q3 2020 | $449,000 | – | 13,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |